Wenjian Bi

Dr. Wenjian Bi


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
WZWei Zhou
Wei Zhou
WBWenjian Bi
Wenjian Bi
ZZZhangchen Zhao
Zhangchen Zhao
KDKushal K. Dey
Kushal K. Dey
KJKarthik A. Jagadeesh
Karthik A. Jagadeesh
SLSeunggeun Lee
Seunggeun Lee
Several biobanks, including UK Biobank (UKBB), are generating large-scale sequencing data. An existing method, SAIGE-GENE, performs well when testing variants with minor allele frequency (MAF) ≤ 1%, but inflation is observed in variance component set-based tests when restricting to variants with MAF ≤ 0.1% or 0.01%. Here, we propose SAIGE-GENE+ with greatly improved type I error control and computational efficiency to facilitate rare variant tests in large-scale data. We further show that incorporating multiple MAF cutoffs and functional annotations can improve power and thus uncover new gene–phenotype associations. In the analysis of UKBB whole exome sequencing data for 30 quantitative and 141 binary traits, SAIGE-GENE+ identified 551 gene–phenotype associations.

9 March 2018 in IEEE Transactions on Automatic Control
Verified
Journal Article
Closed access
YZYanlong Zhao
Yanlong Zhao
TWTing Wang
Ting Wang
WBWenjian Bi
Wenjian Bi
This paper studies the consensus of multi-agent systems with binary-valued communication. We consider a group of agents on an undirected graph with a fixed topology, but differing from most existing work, the information each agent gets from its neighbors are binary-valued measurements. A two-time-scale protocol which alternates estimation and control is constructed: Each agent in the system estimates the states of its neighbors' based on the binary-valued measurements for a short time, during which every agent's state will keep constant; Based on the estimations of its neighbors' states and its own state, each agent designs its own control, by which the state will be updated and then repeats the process of estimation alternating with control. For the state estimation, We propose an identification algorithm without truncation, which is analyzed to be convergent and the convergence rate is given. By the two-time-scale protocol, the system is shown to achieve weak consensus and mean square consensus by using a stochastic Lyapunov analysis and the consensus speed is given. Simulations are given, which are consistent with the theoretical results.

17 January 2022 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
XSXiaohui Shi
Xiaohui Shi
HTHuajing Teng
Huajing Teng
LSLeisheng Shi
Leisheng Shi
WBWenjian Bi
Wenjian Bi
WWWenqing Wei
Wenqing Wei
ZSZhong Sun
Zhong Sun
Optimal methods could effectively improve the accuracy of predicting and identifying candidate driver genes. Various computational methods based on mutational frequency, network and function approaches have been developed to identify mutation driver genes in cancer genomes. However, a comprehensive evaluation of the performance levels of network-, function- and frequency-based methods is lacking. In the present study, we assessed and compared eight performance criteria for eight network-based, one function-based and three frequency-based algorithms using eight benchmark datasets. Under different conditions, the performance of approaches varied in terms of network, measurement and sample size. The frequency-based driverMAPS and network-based HotNet2 methods showed the best overall performance. Network-based algorithms using protein–protein interaction networks outperformed the function- and the frequency-based approaches. Precision, F1 score and Matthews correlation coefficient were low for most approaches. Thus, most of these algorithms require stringent cutoffs to correctly distinguish driver and non-driver genes. We constructed a website named Cancer Driver Catalog (http://159.226.67.237/sun/cancer_driver/), wherein we integrated the gene scores predicted by the foregoing software programs. This resource provides valuable guidance for cancer researchers and clinical oncologists prioritizing cancer driver gene candidates by using an optimal tool.

14 January 2021 in Blood
Verified
Journal Article
Open access
PDF file
PXPeng Xu
Peng Xu
DSDaniel C. Scott
Daniel C. Scott
BXBeisi Xu
Beisi Xu
YYYu Yao
Yu Yao
RFRuopeng Feng
Ruopeng Feng
MWMitchell J. Weiss
Mitchell J. Weiss
The histone mark H3K27me3 and its reader/writer polycomb repressive complex 2 (PRC2) mediate widespread transcriptional repression in stem and progenitor cells. Mechanisms that regulate this activity are critical for hematopoietic development but are poorly understood. Here we show that the E3 ubiquitin ligase F-box only protein 11 (FBXO11) relieves PRC2-mediated repression during erythroid maturation by targeting its newly identified substrate bromo adjacent homology domain–containing 1 (BAHD1), an H3K27me3 reader that recruits transcriptional corepressors. Erythroblasts lacking FBXO11 are developmentally delayed, with reduced expression of maturation-associated genes, most of which harbor bivalent histone marks at their promoters. In FBXO11−/− erythroblasts, these gene promoters bind BAHD1 and fail to recruit the erythroid transcription factor GATA1. The BAHD1 complex interacts physically with PRC2, and depletion of either component restores FBXO11-deficient erythroid gene expression. Our studies identify BAHD1 as a novel effector of PRC2-mediated repression and reveal how a single E3 ubiquitin ligase eliminates PRC2 repression at many developmentally poised bivalent genes during erythropoiesis.

18 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YSYAOYAO SUN
YAOYAO SUN
YLYundan Liao
Yundan Liao
YZYuyanan Zhang
Yuyanan Zhang
ZLZhe Lu
Zhe Lu
YMYuzhuo Ma
Yuzhuo Ma
WYWeihua Yue
Weihua Yue
Childhood maltreatment stands out as a pivotal risk factor for depression, with gene-by-environment interaction serving as a crucial mechanism. Here we perform genome-wide interaction analyzes of childhood maltreatment in the UK Biobank, integrating methylation evidence through colocalization analysis and identifying associated brain structure abnormalities from childhood to adulthood. A genome-wide significant genomic region interacting with childhood maltreatment is identified at 8p11.21 (IDO2 rs7846217, P = 2.02e–08), implicating the tryptophan-kynurenine pathway. Colocalization analysis reveals that IDO2 rs11777027, rs2340953 and rs28631334 are associated with depression in individuals exposed to childhood maltreatment and colocalize with methylation signals in both blood and brain for IDO2. These interactions affect cortical thickness of the left supramarginal gyrus in children (P = 9.72e–04) and adults (P = 1.34e–04), as well as cortical volume in the right angular gyrus in children (P = 1.02e–04). Furthermore, the interactions significantly predict new-onset depression at a 2-year follow-up in children. Stunted increase in cortical thickness of the left middle-anterior cingulate gyrus and sulcus significantly mediates the interaction between childhood maltreatment and IDO2 on childhood depression. These interactions also moderate antidepressant treatment efficacy at 4–6 weeks.

30 September 2022 in Schizophrenia Bulletin
Verified
Journal Article
Closed access
PDF file
YSYaoyao Sun
Yaoyao Sun
YZYuyanan Zhang
Yuyanan Zhang
ZLZhe Lu
Zhe Lu
HYHao Yan
Hao Yan
LGLiangkun Guo
Liangkun Guo
WYWeihua Yue
Weihua Yue
Complex schizophrenia symptoms were recently conceptualized as interactive symptoms within a network system. However, it remains unknown how a schizophrenia network changed during acute antipsychotic treatment. The present study aimed to evaluate the interactive change of schizophrenia symptoms under seven antipsychotics from individual time series. Data on 3030 schizophrenia patients were taken from a multicenter randomized clinical trial and used to estimate the partial correlation cross-sectional networks and longitudinal random slope networks based on multivariate multilevel model. Thirty symptoms assessed by The Positive and Negative Syndrome Scale clustered the networks. Five stable communities were detected in cross-sectional networks and random slope networks that describe symptoms change over time. Delusions, emotional withdrawal, and lack of spontaneity and flow of conversation featured as central symptoms, and conceptual disorganization, hostility, uncooperativeness, and difficulty in abstract thinking featured as bridge symptoms, all showing high centrality in the random slope network. Acute antipsychotic treatment changed the network structure (M-test = 0.116, P < .001) compared to baseline, and responsive subjects showed lower global strength after treatment (11.68 vs 14.18, S-test = 2.503, P < .001) compared to resistant subjects. Central symptoms and bridge symptoms kept higher centrality across random slope networks of different antipsychotics. Quetiapine treatment network showed improvement in excitement symptoms, the one featured as both central and bridge symptom. Our findings revealed the central symptoms, bridge symptoms, cochanging features, and individualized features under different antipsychotics of schizophrenia. This brings implications for future targeted drug development and search for pathophysiological mechanisms.